{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:13:09Z","timestamp":1767139989944,"version":"build-2238731810"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesiologie"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00101-024-01464-8","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T09:02:59Z","timestamp":1727427779000},"page":"713-720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Extrakorporale Verfahren bei der Sepsis","Extracorporeal procedures in sepsis"],"prefix":"10.1007","volume":"73","author":[{"given":"Alice","family":"Bernard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Koeppen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"1","key":"1464_CR1","first-page":"CD008075","volume":"1","author":"EM Borthwick","year":"2017","unstructured":"Borthwick\u00a0EM et\u00a0al (2017) High-volume haemofiltration for sepsis in adults. Cochrane Database Syst Rev 1(1):CD8075","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1464_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13054-018-2181-z","volume":"22","author":"G Ankawi","year":"2018","unstructured":"Ankawi\u00a0G et\u00a0al (2018) Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls. Crit Care 22(1):262","journal-title":"Crit Care"},{"issue":"1","key":"1464_CR3","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1186\/s12879-022-07689-5","volume":"22","author":"Y Li","year":"2022","unstructured":"Li\u00a0Y et\u00a0al (2022) Coupled plasma filtration adsorption for the treatment of sepsis or septic shock: a\u00a0systematic review and meta-analysis. BMC Infect Dis 22(1):714","journal-title":"BMC Infect Dis"},{"issue":"9","key":"1464_CR4","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00134-013-2967-z","volume":"39","author":"O Joannes-Boyau","year":"2013","unstructured":"Joannes-Boyau\u00a0O et\u00a0al (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a\u00a0multicentre randomized controlled trial. Intensive Care Med 39(9):1535\u20131546","journal-title":"Intensive Care Med"},{"key":"1464_CR5","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.12659\/MSM.896819","volume":"22","author":"G Kade","year":"2016","unstructured":"Kade\u00a0G et\u00a0al (2016) Effectiveness of High Cut-Off Hemofilters in the Removal of Selected Cytokines in Patients During Septic Shock Accompanied by Acute Kidney Injury-Preliminary Study. Med Sci Monit 22:4338\u20134344","journal-title":"Med Sci Monit"},{"issue":"3","key":"1464_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1053\/j.ajkd.2003.11.006","volume":"43","author":"S Morgera","year":"2004","unstructured":"Morgera\u00a0S et\u00a0al (2004) Renal replacement therapy with high-cutoff hemofilters: Impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 43(3):444\u2013453","journal-title":"Am J Kidney Dis"},{"issue":"3\u20134","key":"1464_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000369155","volume":"38","author":"G Villa","year":"2014","unstructured":"Villa\u00a0G et\u00a0al (2014) Cytokine removal with high cut-off membrane: review of literature. Blood Purif 38(3\u20134):167\u2013173","journal-title":"Blood Purif"},{"issue":"3","key":"1464_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000446978","volume":"42","author":"C Chelazzi","year":"2016","unstructured":"Chelazzi\u00a0C et\u00a0al (2016) Hemodialysis with High Cut-Off Hemodialyzers in Patients with Multi-Drug Resistant Gram-Negative Sepsis and Acute Kidney Injury: A\u00a0Retrospective, Case-Control Study. Blood Purif 42(3):186\u2013193","journal-title":"Blood Purif"},{"issue":"5","key":"1464_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/01.shk.0000159930.87737.8a","volume":"23","author":"JL Vincent","year":"2005","unstructured":"Vincent\u00a0JL et\u00a0al (2005) A\u00a0pilot-controlled study of a\u00a0polymyxin B\u2011immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 23(5):400\u2013405","journal-title":"Shock"},{"issue":"23","key":"1464_CR10","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1001\/jama.2009.856","volume":"301","author":"DN Cruz","year":"2009","unstructured":"Cruz\u00a0DN et\u00a0al (2009) Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301(23):2445\u20132452","journal-title":"JAMA"},{"issue":"12","key":"1464_CR11","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4240\/wjgs.v11.i12.422","volume":"11","author":"JJ Kim","year":"2019","unstructured":"Kim\u00a0JJ et\u00a0al (2019) Polymyxin\u00a0B hemoperfusion as a\u00a0feasible therapy after source control in abdominal septic shock. World J Gastrointest Surg 11(12):422\u2013432","journal-title":"World J Gastrointest Surg"},{"issue":"14","key":"1464_CR12","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2018.14618","volume":"320","author":"RP Dellinger","year":"2018","unstructured":"Dellinger\u00a0RP et\u00a0al (2018) Effect of Targeted Polymyxin\u00a0B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial. JAMA 320(14):1455\u20131463","journal-title":"JAMA"},{"issue":"12","key":"1464_CR13","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","volume":"44","author":"DJ Klein","year":"2018","unstructured":"Klein\u00a0DJ et\u00a0al (2018) Polymyxin\u00a0B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a\u00a0post hoc analysis of the EUPHRATES trial. Intensive Care Med 44(12):2205\u20132212","journal-title":"Intensive Care Med"},{"issue":"1","key":"1464_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13613-021-00928-z","volume":"11","author":"K Fujimori","year":"2021","unstructured":"Fujimori\u00a0K, Tarasawa\u00a0K, Fushimi\u00a0K (2021) Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a\u00a0nationwide observational study. Ann Intensive Care 11(1):141","journal-title":"Ann Intensive Care"},{"issue":"4","key":"1464_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/1744-9987.13655","volume":"25","author":"K Fujimori","year":"2021","unstructured":"Fujimori\u00a0K, Tarasawa\u00a0K, Fushimi\u00a0K (2021) Effects of polymyxin B hemoperfusion in patients with sepsis requiring continuous hemodiafiltration: Analysis of a\u00a0nationwide administrative database in Japan. Ther Apher Dial 25(4):384\u2013389","journal-title":"Ther Apher Dial"},{"issue":"1","key":"1464_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13054-017-1662-9","volume":"21","author":"K Kogelmann","year":"2017","unstructured":"Kogelmann\u00a0K et\u00a0al (2017) Hemoadsorption by CytoSorb in septic patients: a\u00a0case series. Crit Care 21(1):74","journal-title":"Crit Care"},{"key":"1464_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcrc.2018.11.003","volume":"49","author":"F Hawchar","year":"2019","unstructured":"Hawchar\u00a0F et\u00a0al (2019) Extracorporeal cytokine adsorption in septic shock: A\u00a0proof of concept randomized, controlled pilot study. J\u00a0Crit Care 49:172\u2013178","journal-title":"J Crit Care"},{"issue":"1","key":"1464_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13054-023-04492-9","volume":"27","author":"S Becker","year":"2023","unstructured":"Becker\u00a0S et\u00a0al (2023) Efficacy of CytoSorb(R): a\u00a0systematic review and meta-analysis. Crit Care 27(1):215","journal-title":"Crit Care"},{"key":"1464_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000527774","volume":"200","author":"G Klinkmann","year":"2023","unstructured":"Klinkmann\u00a0G et\u00a0al (2023) Hemoperfusion with CytoSorb(R): Current Knowledge on Patient Selection, Timing, and Dosing. Contrib Nephrol 200:17\u201324","journal-title":"Contrib Nephrol"},{"issue":"1","key":"1464_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13613-022-01017-5","volume":"12","author":"C Scharf","year":"2022","unstructured":"Scharf\u00a0C et\u00a0al (2022) Does the cytokine adsorber CytoSorb((R)) reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a\u00a0prospective observational study. Ann Intensive Care 12(1):44","journal-title":"Ann Intensive Care"},{"issue":"12","key":"1464_CR21","doi-asserted-by":"publisher","first-page":"e030139","DOI":"10.1136\/bmjopen-2019-030139","volume":"9","author":"C Gimenez-Esparza","year":"2019","unstructured":"Gimenez-Esparza\u00a0C et\u00a0al (2019) The premature closure of ROMPA clinical trial: mortality reduction in septic shock by plasma adsorption. BMJ Open 9(12):e30139","journal-title":"BMJ Open"},{"issue":"11","key":"1464_CR22","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00134-021-06501-3","volume":"47","author":"E Garbero","year":"2021","unstructured":"Garbero\u00a0E et\u00a0al (2021) High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a\u00a0multicentre, adaptive, randomised clinical trial. Intensive Care Med 47(11):1303\u20131311","journal-title":"Intensive Care Med"},{"issue":"1","key":"1464_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13054-018-2289-1","volume":"23","author":"S David","year":"2019","unstructured":"David\u00a0S, Stahl\u00a0K (2019) To remove and replace\u2011a role for plasma exchange in counterbalancing the host response in sepsis. Crit Care 23(1):14","journal-title":"Crit Care"},{"issue":"1","key":"1464_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40635-021-00417-4","volume":"9","author":"K Stahl","year":"2021","unstructured":"Stahl\u00a0K et\u00a0al (2021) Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shock. Intensive Care Med Exp 9(1):57","journal-title":"Intensive Care Med Exp"},{"issue":"6","key":"1464_CR25","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1111\/iwj.14059","volume":"20","author":"L Zhang","year":"2023","unstructured":"Zhang\u00a0L et\u00a0al (2023) An inquiry into the treatment of sepsis using plasma exchange therapy: A\u00a0systematic review and meta-analysis. Int Wound\u00a0J 20(6):1979\u20131986","journal-title":"Int Wound J"},{"issue":"1","key":"1464_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13063-023-07300-5","volume":"24","author":"S David","year":"2023","unstructured":"David\u00a0S et\u00a0al (2023) EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock\u2014a study protocol for a\u00a0randomized, prospective, multicenter, open-label, controlled, parallel-group trial. Trials 24(1):277","journal-title":"Trials"}],"updated-by":[{"DOI":"10.1007\/s00101-025-01548-z","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000}}],"container-title":["Die Anaesthesiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-024-01464-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-024-01464-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-024-01464-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T02:03:29Z","timestamp":1748397809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-024-01464-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1464"],"URL":"https:\/\/doi.org\/10.1007\/s00101-024-01464-8","relation":{},"ISSN":["2731-6858","2731-6866"],"issn-type":[{"value":"2731-6858","type":"print"},{"value":"2731-6866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"27 September 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Die Originalversion dieses Beitrags wurde korrigiert: Im Abschnitt \u201eHigh-Volume- und Very-High-Volume-H\u00e4mofiltration\u201d und in Abbildung\u00a01 waren die Angaben der Very-High-Volume-H\u00e4mofiltration f\u00e4lschlicherweise mit >\u202f70\u202fml\/kg\/h angegeben.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Zu diesem Beitrag wurde ein Erratum ver\u00f6ffentlicht:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00101-025-01548-z","URL":"https:\/\/doi.org\/10.1007\/s00101-025-01548-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"M.\u00a0Koeppen\n                      : A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Deutsche Forschungsgemeinschaft Sachbeihilfe.\u00a0\u2013 Vortragshonorar Dr. Franz K\u00f6hler Chemie GmbH.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: angestellter An\u00e4sthesist, Klinik f\u00fcr An\u00e4sthesiologie und Intensivmedizin, Universit\u00e4tsklinikum T\u00fcbingen.\n                      A.\u00a0Bernard\n                      : A.\u00a0Finanzielle Interessen: A.\u00a0Bernard gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: angestellte An\u00e4sthesistin, Universit\u00e4tsklinikum f\u00fcr An\u00e4sthesiologie und Intensivmedizin (T\u00fcbingen).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}